𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

✍ Scribed by Sven Pålhagen; Hongshi Qi; Björn Mårtensson; Jan Wålinder; Ann-Kathrine Granérus; Per Svenningsson

Publisher
Springer
Year
2009
Tongue
English
Weight
277 KB
Volume
257
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Depression and major depressive disorder
Depression and major depressive disorder in patients with Parkinson's disease
✍ Takeshi Inoue; Mayumi Kitagawa; Teruaki Tanaka; Shin Nakagawa; Tsukasa Koyama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The prevalence of depression in Parkinson's disease (PD) varies greatly. In this study, we investigated major depressive disorder (MDD) and depressive symptoms without MDD in patients with PD. The psychopathological characteristics of depressive symptoms were assessed by a psychiatric i

Bereitschaftspotential in depressed and
Bereitschaftspotential in depressed and non-depressed patients with Parkinson's disease
✍ Saša R. Filipović; Nadežda Šternić; Marina Svetel; Nataša Dragašević; Dušica Leč 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Impaired initiation and slowed execution of movements are two of the principal characteristics of Parkinson's disease (PD). A similar pattern of movement impairments (psychomotor retardation) can be seen frequently in patients with idiopathic depression. In addition, affective disorders

Depression in patients with Parkinson's
Depression in patients with Parkinson's disease
✍ Jeffrey L. Cummings; Donna L. Masterman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control

IL-6 levels decrease with SSRI treatment
IL-6 levels decrease with SSRI treatment in patients with major depression
✍ Ayse Devrim Basterzi; Çigdem Aydemir; Cebrail Kisa; Sabahat Aksaray; Verda Tuzer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

## Objective: Some evidence indicates that an immune response with an increased production of proinflammatory cytokines often accompanies major depression. the objective of this study was to examine the serum levels of il-6 in patients with major depression and the changes occurring in il-6 levels

Subthreshold depression in patients with
Subthreshold depression in patients with Parkinson's disease and dementia––clinical and demographic correlates
✍ Uwe Ehrt; Kolbjørn Brønnick; Peter Paul De Deyn; Murat Emre; Sibel Tekin; Roger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract ## Background About 40% of the patients with Parkinson's disease (PD) have depressive symptoms, either major depression (MD) or subthreshold depression. Depression was found to be associated with age and age at onset of PD, female gender, more severe parkinsonism, in particular with le